We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$301B
AUM Growth
+$28B
Cap. Flow
+$8.83B
Cap. Flow %
2.93%
Top 10 Hldgs %
16.6%
Holding
3,648
New
163
Increased
2,481
Reduced
676
Closed
240

Sector Composition

Rank Sector Weight
1 Technology 20.17%
2 Financials 13.07%
3 Healthcare 12.05%
4 Consumer Discretionary 10.98%
5 Industrials 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XERS icon
3301
Xeris Biopharma Holdings
XERS
$1.45B
$92K ﹤0.01%
22,478
-99,459
-82% -$380K
SUP
3302
DELISTED
Superior Industries International
SUP
$90K ﹤0.01%
10,350
CFMS
3303
DELISTED
Conformis, Inc. Common Stock
CFMS
$89K ﹤0.01%
3,085
GORO icon
3304
Goldgroup Mining Inc.
GORO
$155M
$88K ﹤0.01%
34,097
-143,162
-81% -$396K
QCLS
3305
Q/C Technologies Inc
QCLS
$19.7M
$88K ﹤0.01%
+5
New +$73.5K
SBBP
3306
DELISTED
Strongbridge Biopharma plc.
SBBP
$87K ﹤0.01%
29,233
-74,519
-72% -$197K
CFRX
3307
DELISTED
ContraFect Corporation
CFRX
$87K ﹤0.01%
246
-491
-67% -$161K
TREC
3308
DELISTED
Trecora Resources
TREC
$86K ﹤0.01%
10,224
-52,180
-84% -$420K
UTI icon
3309
Universal Technical Institute
UTI
$2.26B
$85K ﹤0.01%
13,059
-69,002
-84% -$407K
WRAP icon
3310
Wrap Technologies
WRAP
$90.9M
$83K ﹤0.01%
10,465
-24,620
-70% -$169K
RVSB icon
3311
Riverview Bancorp
RVSB
$107M
$82K ﹤0.01%
11,437
-44,326
-79% -$307K
LINC icon
3312
Lincoln Educational Services
LINC
$1.38B
$81K ﹤0.01%
10,364
OVID icon
3313
Ovid Therapeutics
OVID
$427M
$77K ﹤0.01%
19,452
-99,326
-84% -$392K
EVFM
3314
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$77K ﹤0.01%
4,509
-8,568
-66% -$162K
MNOV icon
3315
MediciNova
MNOV
$63.5M
$76K ﹤0.01%
17,843
-93,762
-84% -$404K
NBSE
3316
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$76K ﹤0.01%
786
-1,272
-62% -$141K
EMAN
3317
DELISTED
eMagin Corporation
EMAN
$76K ﹤0.01%
21,824
MRKR icon
3318
Marker Therapeutics
MRKR
$18.5M
$75K ﹤0.01%
2,656
-4,715
-64% -$124K
PXLW icon
3319
Pixelworks
PXLW
$37.2M
$75K ﹤0.01%
1,830
-8,334
-82% -$327K
PVLA
3320
Palvella Therapeutics
PVLA
$2.05B
$75K ﹤0.01%
243
-1,472
-86% -$323K
SVRA icon
3321
Savara
SVRA
$1.08B
$73K ﹤0.01%
42,882
-57,173
-57% -$103K
TUSK icon
3322
Mammoth Energy Services
TUSK
$122M
$73K ﹤0.01%
15,843
XAIR icon
3323
Beyond Air
XAIR
$3.97M
$73K ﹤0.01%
28
-113
-80% -$247K
ASAP
3324
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$73K ﹤0.01%
2,034
-9,066
-82% -$411K
AQMS icon
3325
Aqua Metals
AQMS
$9.78M
$71K ﹤0.01%
118

Similar funds

Charles Schwab's Q2 2021 Portfolio in Review

As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
  • Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
  • Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
  • Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
  • Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
  • Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
  • Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.

Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.